Purdue Pharma Introduces Nalmefene HCl Injection, 2mg/2mL (1mg/1mL) in the U.S. for the Treatment of Known or Suspected Overdose with Natural or Synthetic Opioids
Harm Reduction Therapeutics to Receive Additional Funding for the Development of its Over-the-Counter Opioid Overdose Reversal Medication from Purdue Pharma after Bankruptcy Court Approval
Purdue Pharma L.P. to Provide Opportunities for Investigator-Initiated Research to Examine Opioid Overdose Reversal in Emergency Medicine Settings
Opinion – Steve Miller: Purdue Pharma chair on ‘tragic’ settlement decision; Stamford Advocate
December 31, 2021
The U.S. District Court’s decision vacating the settlement reached in Purdue’s bankruptcy proceedings threatens not only to upend U.S. bankruptcy law but also to significantly delay —and possibly prevent entirely — billions of dollars from being used to address the opioid crisis. It is a regrettable and tragic outcome that could have been, and hopefully still can be, avoided.
In 2017, Nicole Wesley, MD, MBA, MHA, lost her father to congestive heart failure. When she inherited his home in Warren, Ohio, Nicole knew she could do something special with it. Five months later, Nikki’s House – a recovery home for women healing from substance use disorder – opened its doors to the first two women. Five years later, Nikki’s House has given approximately 250 women the opportunity to live sober lives.
Ethan Hershman has been in recovery from substance use disorder for 28 years. While he’s never once relapsed, he’s seen his fair share of people who haven’t been as fortunate and, in many tragic cases, have lost their lives. He finally asked himself, “why?”
Mothers seeking treatment for substance use disorder often must choose between taking care of their children and taking care of themselves. Renewal House is offering mothers in Middle Tennessee a different option – one where they don’t have to choose.